Daniel R. Kaul
Expertise in
23
conditions

Dr. Daniel R. Kaul

Infectious Disease
1500 E Medical Center Dr, Floor 3 Reception D, 
Ann Arbor, MI 
Accepting New Patients
Offers Telehealth
Expertise in
23
conditions
1500 E Medical Center Dr, Floor 3 Reception D, 
Ann Arbor, MI 

Overview

Daniel Kaul is an Infectious Disease provider practicing medicine in Ann Arbor, Michigan.

Dr. Kaul is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Cytomegalic Inclusion Disease, Cytomegalovirus Infection, HIV/AIDS, and Myelitis.

Dr. Kaul is board certified in Infectious Disease. He is actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 2 clinical trials. Dr. Kaul is currently accepting new patients.

Specialties

Infectious Disease

Licenses

Internal Medicine in MI

Board Certifications

Infectious Disease

Fellowships

University of Michigan Health System, Internal Medicine Infectious Disease, 2001

Hospital Affiliations

University Of Michigan Health System

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Michigan Health
  • HMO
  • INSURANCE PLAN
  • MEDICARE MAPD
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 15 Less Insurance Carriers -

Locations

Taubman Center
1500 E Medical Center Dr, Floor 3 Reception D, Ann Arbor, MI 48109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Prospective Observational Study for the Long-term Follow-up of Subjects Previously Enrolled in Selected Clinical Studies of CMX001.
A Prospective Observational Study for the Long-term Follow-up of Subjects Previously Enrolled in Selected Clinical Studies of CMX001.
Enrollment Status: Terminated
Publish Date: May 17, 2019
Intervention Type: Drug
View 1 Less Clinical Trial

72 Total Publications

IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients.
IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 23, 2026
Similar Doctors
Expertise in
16
conditions
Dr. Tejal N. Gandhi
Infectious Disease
Expertise in
16
conditions
Dr. Tejal N. Gandhi
Infectious Disease
Referral may be required

Taubman Center

1500 E Medical Center Dr, Floor 3 Reception D, 
Ann Arbor, MI 
 (0.1 miles away)
734-647-5899
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Tejal Gandhi is an Infectious Disease provider practicing medicine in Ann Arbor, Michigan. Dr. Gandhi is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Asymptomatic Bacteriuria, Pneumonia, Chronic Recurrent Multifocal Osteomyelitis, and Osteomyelitis. Dr. Gandhi is board certified in Infectious Disease. Dr. Gandhi is currently accepting new patients.

Expertise in
15
conditions
Dr. Lindsay A. Petty
Infectious Disease | Pediatrics
Expertise in
15
conditions
Dr. Lindsay A. Petty
Infectious Disease | Pediatrics
Referral may be required

Taubman Center

1500 E Medical Center Dr, Floor 3 Reception D, 
Ann Arbor, MI 
 (0.1 miles away)
734-647-5899
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lindsay Petty is an Infectious Disease specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Petty is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Asymptomatic Bacteriuria, Pneumonia, COVID-19, and Febrile Neutropenia. Dr. Petty is board certified in Infectious Disease. Dr. Petty is currently accepting new patients.

Expertise in
6
conditions
Dr. Anurag N. Malani
Infectious Disease
Expertise in
6
conditions
Dr. Anurag N. Malani
Infectious Disease
Referral may be required

Trinity Health Ann Arbor Hospital

5301 McAuley Dr, 
Ypsilanti, MI 
 (3.8 miles away)
734-337-1100
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Anurag Malani is an Infectious Disease provider practicing medicine in Ypsilanti, Michigan. Dr. Malani is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Asymptomatic Bacteriuria, Pneumonia, Arachnoiditis, and Sporotrichosis. Dr. Malani is currently accepting new patients.

Frequently Asked Questions about Dr. Daniel R. Kaul

How do I make an appointment with Dr. Daniel R. Kaul?

You can book an appointment with Dr. Daniel R. Kaul by calling their office at 734-647-5899. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Daniel R. Kaul a top-rated expert for Cytomegalic Inclusion Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Daniel R. Kaul is classified as an Elite expert for Cytomegalic Inclusion Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Daniel R. Kaul specialize in?

While Dr. Daniel R. Kaul is a Infectious Disease, they have specific expertise in Cytomegalic Inclusion Disease, Cytomegalovirus Infection, and HIV/AIDS. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Daniel R. Kaul participate in research or clinical trials?

Yes. Dr. Daniel R. Kaul has published 72 articles and abstracts on conditions like Cytomegalic Inclusion Disease. You can view a list of Dr. Daniel R. Kaul's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Daniel R. Kaul accept my insurance?

Dr. Daniel R. Kaul accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-647-5899 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kaul's expertise for a condition
ConditionClose
View All 17 Advanced Conditions
View All 47 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile